Current and historical daily PE Ratio for Huadong Medicine Co Ltd (
SZSE:000963
) from 2000 to May 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Huadong Medicine stock (SZSE:000963) PE ratio as of May 13 2024 is 20.36.
More Details
Huadong Medicine Co Ltd (SZSE:000963) PE Ratio (TTM) Chart
Huadong Medicine Co Ltd (SZSE:000963) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1182
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Huadong Medicine PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-13 | 20.4 | 2024-03-05 | 20.3 |
| 2024-05-13 | 20.4 | 2024-03-04 | 20.7 |
| 2024-05-10 | 19.9 | 2024-03-01 | 20.6 |
| 2024-05-09 | 20.1 | 2024-02-29 | 20.8 |
| 2024-05-08 | 19.8 | 2024-02-28 | 20.5 |
| 2024-05-07 | 20.1 | 2024-02-27 | 20.6 |
| 2024-05-06 | 20.1 | 2024-02-26 | 20.4 |
| 2024-04-30 | 19.6 | 2024-02-23 | 20.4 |
| 2024-04-29 | 19.6 | 2024-02-22 | 20.4 |
| 2024-04-26 | 19.5 | 2024-02-21 | 20.4 |
| 2024-04-25 | 19.5 | 2024-02-20 | 20.5 |
| 2024-04-24 | 19.3 | 2024-02-19 | 20.1 |
| 2024-04-23 | 19.6 | 2024-02-08 | 19.5 |
| 2024-04-22 | 18.9 | 2024-02-07 | 19.5 |
| 2024-04-19 | 18.7 | 2024-02-06 | 19.4 |
| 2024-04-18 | 18.7 | 2024-02-05 | 17.9 |
| 2024-04-17 | 17.9 | 2024-02-02 | 17.9 |
| 2024-04-16 | 17.5 | 2024-02-01 | 18.3 |
| 2024-04-15 | 17.5 | 2024-01-31 | 17.9 |
| 2024-04-12 | 17.2 | 2024-01-30 | 18.3 |
| 2024-04-11 | 17.5 | 2024-01-29 | 19.1 |
| 2024-04-10 | 17.7 | 2024-01-26 | 19.5 |
| 2024-04-09 | 18.0 | 2024-01-25 | 20.4 |
| 2024-04-08 | 17.6 | 2024-01-24 | 20.3 |
| 2024-04-03 | 18.5 | 2024-01-23 | 20.3 |
| 2024-04-02 | 18.4 | 2024-01-22 | 20.2 |
| 2024-04-01 | 18.7 | 2024-01-19 | 21.3 |
| 2024-03-29 | 18.4 | 2024-01-18 | 21.5 |
| 2024-03-28 | 18.3 | 2024-01-17 | 21.4 |
| 2024-03-27 | 19.1 | 2024-01-16 | 22.1 |
| 2024-03-26 | 19.1 | 2024-01-15 | 21.9 |
| 2024-03-25 | 19.2 | 2024-01-12 | 22.5 |
| 2024-03-22 | 19.6 | 2024-01-11 | 22.3 |
| 2024-03-21 | 20.3 | 2024-01-10 | 21.9 |
| 2024-03-20 | 20.6 | 2024-01-09 | 21.7 |
| 2024-03-19 | 20.6 | 2024-01-08 | 21.9 |
| 2024-03-18 | 20.8 | 2024-01-05 | 22.6 |
| 2024-03-15 | 20.9 | 2024-01-04 | 24.0 |
| 2024-03-14 | 20.6 | 2024-01-03 | 25.1 |
| 2024-03-13 | 20.4 | 2024-01-02 | 25.0 |
| 2024-03-12 | 20.4 | 2023-12-29 | 25.6 |
| 2024-03-11 | 20.0 | 2023-12-28 | 24.7 |
| 2024-03-08 | 19.8 | 2023-12-27 | 25.4 |
| 2024-03-07 | 19.4 | 2023-12-26 | 25.4 |
| 2024-03-06 | 20.2 | 2023-12-25 | 25.8 |
Huadong Medicine Co Ltd (SZSE:000963) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Huadong Medicine Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE0000011S1
Share Class Description:
SZSE:000963: Class ACompare
Compare
Traded in other countries / regions
000963.China IPO Date
2000-01-27Description
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers